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Biology of PrPsc accumulation in two natural scrapie-infected
sheep flocks
Patrick Caplazi, Katherine O’Rourke, Cynthia Wolf, Daniel Shaw, Timothy V. Baszler1
Abstract. Sheep scrapie is a prion disease that requires interaction of exogenous prions with host prion
protein (PrP) supporting prion formation. Disease is associated with deposition of a host-generated conforma-
tional variant of PrP, PrPsc, in a variety of tissues, including brain, resulting in fatal spongiform encephalopathy.
Efficiency of PrPsc formation is determined by polymorphisms in the PrP-coding sequence. This article adds to
previous data of natural sheep scrapie, concentrating on the effect of host genotype and age on PrPsc accumu-
lation patterns during preclinical and clinical disease. Two entire scrapie-infected, predominantly Suffolk-cross,
sheep flocks euthanized for regulatory purposes were genotyped and analyzed for PrPsc deposition in various
tissues using single- and dual-label immunohistochemistry. Scrapie, as defined by PrPsc deposition, occurred in
13/80 sheep. Preclinical disease was evident in nearly 70% of infected sheep, ranging in age from 14 months
to 7 years. PrPsc accumulated systemically in the nervous tissue, various lymphoid tissues, both alimentary tract
related and non–alimentary tract related, and the placenta. Clinical neurological illness was always associated
with spongiform encephalopathy and PrPsc deposition in the brain. Only 6 of 9 sheep with preclinical scrapie
had PrPsc deposition in the brain but widespread PrPsc deposition in peripheral lymphoid tissue, supporting
previous data showing peripheral PrPsc accumulation preceding deposition in the brain. PrPsc colocalized with
a marker for follicular dendritic cells throughout the lymphoid system. PrPsc also accumulated in the peripheral
nervous system, particularly the nervous supply of the gastrointestinal tract. Abundant PrPsc was evident in
trophoblast cells of placentomes but not in the endometrium, myometrium, or associated nervous plexus. PrPsc
deposits were not observed in the mammary parenchyma or bone marrow. Scrapie susceptibility was defined
genetically by PrP codon 171: PrPsc deposition was restricted to PrP genotype AA136RR154QQ171 in 12/13 cases
or AV136RR154QQ171 in 1/13 cases. The earliest accumulation was observed in the single VRQ/ARQ heterozygous
animal, consistent with the reported high scrapie susceptibility and brief incubation period observed in breeds
with predominance of the V136R154Q171 allele. Disease occurred within, as well as independent of, mother–
daughter lines, suggesting both maternal and nonmaternal transmission in the flocks.
Introduction
Scrapie is the prototype of those transmissible spon-
giform encephalopathies (TSE) with a combined in-
fectious and genetic pathogenesis and occurs naturally
in sheep and goats.10–12 The importance of oral uptake
of infectious material for transmission12,29,30 and the
contribution of lymphoid tissue related to the alimen-
tary tract for local amplification of PrPsc, a confor-
mational variant of prion protein (PrP), have been rec-
ognized12,18 and is supported by experimental mod-
els.3,4 Data indicate that scrapie generally follows oral
uptake of prions and includes a preclinical phase char-
acterized by local amplification of PrPsc in the lym-
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phoid tissue of the alimentary tract and transport
through the peripheral nervous system into the central
nervous system (CNS).8,13,14 PrPsc accumulation pat-
terns vary greatly among prion diseases, and suscep-
tibility to scrapie is greatly modified by polymor-
phisms in the PrP gene, PRNP. This article, in support
of previous reports, describes the biology of natural
scrapie in 2 sheep flocks with specific reference to the
tissue and cellular topography of PrPsc during preclin-
ical and clinical disease, the role of host genotype in
disease incubation, and potential modes of agent trans-
mission.
Materials and methods
Animals and selection of tissue samples. Sheep (n 5 80)
from 2 privately owned flocks were euthanized and necrop-
sied for disease regulatory purposes after observation of in-
dex clinical scrapie cases. Flock A, containing 50 sheep,
originated from North Central United States, and flock B,
containing 30 sheep, originated from the Pacific Northwest
United States. Both flocks consisted predominately of Suf-
folk (n 5 51) or Suffolk-cross sheep (n 5 22), with the
remainder being Black desert (n 5 3) or White desert (n 5
4). Sheep ranged in age from 12 mo to .6 yr, the majority
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Table 1. Age distribution of PrPsc and disease status in 2 scrapie-infected flocks.
Age
PrPsc negative*
n % total‡
Similar age
(%)§
PrPsc positive†
Clinical
n % total
Similar age
(%)
Preclinical
n % total
Similar age
(%)
#14 mo
2 yr
3 yr
4 yr
5 yr
$6 yr
45
4
7
6
3
2
56.25
5.00
8.75
7.50
3.75
2.50
98
50
63.6
75
75
66.6
0
0
1
2
1
0
0
0
1.25
2.5
1.25
0
0
0
9
25
25
0
1
4
3
0
0
1
1.25
5.0
3.75
0
0
1.25
2
50
36.3
0
0
33.3
Total 67 83.75 NA\ 4 5.0 NA 9 11.25 NA
* No PrPsc immunoreactivity in any tissue.
† PrPsc immunoreactivity in at least 1 tissue.
‡ Percentage of total number of sheep in 2 flocks.
§ Percentage of number of sheep of similar age.
\ NA 5 not applicable.
being #2 yr old (n 5 54). Information on clinical signs and
familial lineage was collected for individual sheep.
Various tissues were collected postmortem and fixed in
10% formalin for analysis of microscopic lesions by histo-
pathology and PrPsc deposition by immunohistochemistry.
Anatomic sites of tissues for PrPsc immunohistochemistry
were 1) CNS (brain), 2) alimentary tract (jejunum, ileum,
colon, rectum) and related lymph nodes, 3) lymphoid system
not related to the alimentary tract (third eyelid, spleen, and
various lymph nodes [superficial cervical, subiliac, medial
iliac]), 4) mammary gland and related lymph node, 5) he-
matopoietic tissues (bone marrow), and 6) reproductive/fetal
tissues (uterus, placenta, fetal spleen, fetal ileum).
Determination of PrP genotype. Whole blood was col-
lected for isolation of genomic DNA from the leukocyte
fraction. Amino acid polymorphisms at PrP codons 136, 154,
and 171 were determined by DNA sequencing using com-
mercially available services.a,b DNA sequencing followed
PCR amplification using primers specific for the entire PrP-
coding sequence, as described previously.38
Immunohistochemical detection of PrPsc. Single-label im-
munohistochemistry for PrPsc was performed on formalin-
fixed, paraffin-embedded tissues using heat-induced antigen
retrieval and 90% formic acid pretreatment as described pre-
viously.25 F89.160.1.5 (F89), a monoclonal antibody (mAb)
to ruminant PrP targeting a conserved epitope at residues
142 through 145 of ovine PrP,26 was used at a concentration
of 1 mg/ml in a labeled streptavidin-biotin–based system.c
Amino-ethyl-carbazole (AEC) was used as a chromogen.d
Positive control tissue, consisting of brain or lymph node
from a known scrapie-positive sheep, was included in each
run to confirm immunoreactivity of the appropriate pattern
and intensity in lymphoid follicle germinal centers and in
the neuropil of the brain as described previously.26,27 Nega-
tive controls consisted of a negative antibody control and a
negative tissue control. Negative antibody was an irrelevant
isotype-matched primary antibody (anti–Neospora caninum
mAb Nc-5B6-25, 1 mg/ml) reacted with each test slide to
ensure the lack of nonspecific binding by linker or signal
amplification reagents to tissue sections. Negative tissue
control consisted of brain and lymph node of a known scra-
pie-negative sheep reacted with anti-PrP mAb F89 to ensure
absence of PrPsc immunoreactivity.
Conditions of antigen retrieval and pretreatment proce-
dures were adapted for dual immunohistochemistry using
antibodies toward cell-specific markers in conjunction with
F89 for PrPsc. Antibodies toward cell markers included mAb
CNA.42 for follicular dendritic cells (FDCs),e anti-CD3 rab-
bit antiserum for T lymphocytes,d anti-CD79a mAb for B
lymphocytes,e anti–neuron-specific enolase rabbit antiserum
for ganglion cells,d and mAb NCL-LN5 for macrophage/
monocytes.f Dual labeling was carried out sequentially using
cell-specific antibodies with peroxidase-based color reaction
(red) in the first sequence and F89 with alkaline phospha-
tase–based color reaction (black) in the second sequence.
After development of the red signal (AEC) under micro-
scopic control, slides were incubated with 0.3 M glycine HCl
at pH 1.8 at room temperature overnight to denature poten-
tial binding sites on linker reagents from the first sequence;
then, residual biotin binding was blocked with an avidin-
biotin–blocking kit.g As a control for the efficacy of blocking
steps between sequences (i.e., nonspecific staining of the
second immunostaining sequence), slides were treated with
the full first sequence except for the color reaction and then
subjected to the blocking steps and the full second sequence
omitting primary antibody incubation. Absence of black sig-
nal (second signal) in these slides indicated effectiveness of
disruptive glycine HCl treatment and avidin–biotin block be-
tween the sequences and, thus, absence of cross-reactivity
between the 2 sequences (i.e., black signal represented PrPsc
without cross-reactivity with cell markers).
Results
Age distribution of PrPsc accumulation. Age of the
sheep ranged from 12 months to 7 years of age; 67%
of sheep were 24 months or younger (Table 1). Scra-
pie, as defined by neural or extraneural deposition of
PrPsc, was diagnosed in 13 of 80 sheep (16.25%),
whereas 67 of 80 sheep (83.75%) had no detectable
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Table 2. Tissue distribution of PrPsc immunoreactivity in PrPsc-positive sheep.
Tissue* Total† % total Clinical‡ Preclinical§
Central nervous system
Brain 10/13 77 4/4 6/9
Alimentary tract and related lymphoid tissues
Jejunum
Ileum
Colon
Rectum
7/13
12/13
12/13
9/12
54
92
92
75
3/4
4/4
4/4
3/4
4/9
8/9
8/9
6/8
Medial iliac LN
Anorectal LN
Palatine tonsil
Retropharyngeal LN
13/13
9/11
12/12
13/13
100
82
100
100
4/4
2/2
4/4
4/4
9/9
7/9
8/8
9/9
Lymphoid tissues not related to alimentary tract
Third eyelid
Spleen
Subiliac LN
12/13
9/9
10/11
92
100
91
4/4
3/3
4/4
8/9
6/6
6/7
Mammary gland and related LN
Mammary gland
Mammary LN
1/13\
12/12
8
100
1/4\
4/4
0/9
8/8
Hematopoietic
Bone marrow 0/13 0 0/4 0/9
Reproductive/fetal
Placenta
Uterus
Fetal spleen
Fetal ileum
8/9
0/13
0/2
0/2
89
0
0
0
2/3
0/4
6/6
0/9
* LN 5 lymph node.
† Sheep with PrPsc-positive tissue/total sheep examined.
‡ Clinical scrapie sheep with PrPsc-positive tissue/total clinical scrapie sheep examined.
§ Preclinical scrapie sheep with PrPsc-positive tissue/total preclinical scrapie sheep examined.
\ PrPsc deposits restricted to the germinal center of an interstitial lymphoid follicle.
PrPsc in any tissue. Sheep with PrPsc deposits ranged
from 14 months to more than 6 years. Disease oc-
curred in 12 of 34 sheep aged $2 years or 12 of 18
genetically susceptible sheep aged $2 years, indicating
high disease prevalence in this age category of 43 or
67%, respectively.
Clinical neurological disease typical of scrapie was
observed in 4 of the 13 sheep with PrPsc deposits. PrPsc
deposits and spongiform lesions were widespread
within the 4 coronal planes examined (brain stem at
the obex, middle cerebellar peduncle, rostral mesen-
cephalic colliculi, and thalamus). The remaining 9
sheep with PrPsc deposits were preclinical and ranged
in age from 14 months to more than 6 years.
Tissue distribution of PrPsc deposition. PrPsc depos-
its were widespread in all scrapie-infected sheep (Ta-
ble 2). Detection of PrPsc in non–central nervous tis-
sues was biased by the density of lymphoid follicles
in the examined sample. For example, deposits were
more frequently observed in ileum and colon (12 of
13 samples) than in rectum and jejunum (7 of 13 and
9 of 12 samples, respectively).
PrPsc deposits in the brain were detected in all (4 of
4) clinical sheep, but only in 6 of 9 preclinical sheep.
Central nervous deposits were thus less frequent (10
of 13; 77% of affected sheep) than alimentary tract–
related deposits (13 of 13; 100%). Deposits in extra-
neural tissue always accompanied PrPsc deposits in the
brain.
PrPsc deposits were generalized in alimentary tract–
associated and non-alimentary tract–associated lym-
phoid tissue. PrPsc deposits occurred in the placentas
of 8 of 9 scrapie-infected sheep that were pregnant. Of
the 8 placenta-positive ewes, 6 were preclinical, 2 of
which were without deposits in the brain. PrPsc was
not detected in the bone marrow, secretory parenchy-
ma of the mammary gland, uterus, or fetus of any scra-
pie-infected sheep.
Cellular distribution of PrPsc deposition. In lym-
phoid tissues, PrPsc deposits were localized to the ger-
minal centers of lymphoid follicles in a random, mul-
tifocal pattern (Fig. 1A). Cells that accumulated PrPsc
in lymphoid tissues were similar regardless of the an-
atomical location of the lymphoid tissue. The intensity
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Figure 1. Microanatomic distribution of PrPsc accumulation in sheep with clinical and preclinical scrapie detected by single- and dual-
label immunohistochemistry. A, ileum (preclinical). Multifocal, coarsely granular deposits of PrPsc (arrows) in the germinal center of a gut-
associated lymphoid follicle (G) subjacent to intestinal crypts (C). PrPsc deposits were not detected in intestinal epithelium. Single-label
immunohistochemistry using F89 mAb–red. 1003. B, retropharyngeal lymph node (clinical). Multifocal PrPsc accumulation (black) in the
germinal center (G) of a lymphoid follicle; no immunoreactivity in the mantle zone (M). PrPsc (black) mostly colocalized with dendrites
and cell bodies of FDCs (red). Dual-label immunohistochemistry using mAbs CNA.42-red (FDC) and F89-black (PrPsc). 4003. C, mes-
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Table 3. PrP genotype frequency of PrPsc and disease status in 2 scrapie-infected flocks.
Genotype PrPsc negative PrPsc positive Clinical Preclinical
AA136RR154QQ171
AA136RR154QR171
AA136RR154RR171
AA136RH154QQ171
AV136RR154QQ171
AV136RR154QR171
34
27
2
1
1
2
12
0
0
0
1
0
4
0
0
0
0
0
8*
0
0
0
1†
0
* PrPsc positive at $24 mo of age.
† PrPsc positive at 14 mo of age.
←
enteric lymph node (preclinical). Higher magnification of PrPsc (black) colocalized (arrows) with dendrites and cell bodies of FDCs (red).
Dual-label immunohistochemistry using CNA.42-red (FDC) and F89 mAb–black (PrPsc). 6303. D, ileum (clinical). Finely granular deposits
of PrPsc (black) occur throughout the myenteric plexus (red). Colocalization (arrows) of PrPsc (black) with nerve fibers of the myenteric
plexus (red). Dual-label immunohistochemistry using anti-neuron-specific enolase–red (ganglia neurons and fibers) and F89 mAb–black
(PrPsc). 1003. E, medial iliac lymph node germinal center (clinical). PrPsc deposits (black) do not colocalize with T lymphocytes (red) that
are sparsely scattered throughout the germinal center (G) or packed within the adjacent paracortex (P). Dual-label immunohistochemistry
using anti-CD3–red (T-lymphocyte) and F89 mAb–black (PrPsc). 4003. F, subiliac lymph node germinal center (clinical). PrPsc (black)
does not colocalize with B lymphocytes (red) in the germinal center (G). Dual-label immunohistochemistry using anti-CD79a–red (B-cell)
and F89 mAb–black (PrPsc). 4003. G, placenta (placentome) (clinical). PrPsc (red) localized to chorionic epithelium of the fetal cotyledon
(arrows). No immunoreactivity of maternal caruncle epithelium (M). Single-label immunohistochemistry using F89 mAb–red (PrPsc). 2003.
H, placenta (placentome) (clinical). PrPsc (red) localized to the cytoplasm of mononuclear and multinuclear chorionic epithelial cells of the
fetal cotyledon (arrows). Some immunoreactivity free in the extracellular space between fetal cotyledon and maternal caruncle (arrowhead).
Single-label immunohistochemistry using F89 mAb–red (PrPsc). 6303.
of immunoreactivity varied among individual sheep
but did not correlate with age or clinical status. Most
immunoreactivity was detected in multipolar cells
characteristic of FDCs (Fig. 1B). Using dual-label im-
munohistochemistry, detecting specific cellular mark-
ers and PrPsc, PrPsc colocalized with CNA.42, a marker
specific for FDC (Fig. 1B, 1C).19,22,33 PrPsc did not co-
localize with CD3, a marker for T lymphocytes (Fig.
1E), or CD79a, a B-lymphocyte marker (Fig. 1F).
Rarely, PrPsc colocalized with a macrophage marker
(NCL-LN5) in macrophages in the medulla of lymph
nodes but not within germinal center macrophages (not
shown).
PrPsc deposition in nonlymphoid tissues (outside the
CNS) was restricted to neurons and chorionic epithe-
lium. In the gut, PrPsc was regularly detected within
the perikarya and neurites of the submucosal and my-
enteric plexus, colocalizing with neuron-specific eno-
lase, a marker for neural cells (Fig. 1D). Axonal and
somatic PrPsc deposits were also detected in the mes-
enteric ganglia (not shown). No PrPsc deposits were
detected in gut epithelial cells, including M cells of
Peyer’s patches, smooth muscle cells, endothelial cells,
or round cells in the lamina propria. Placental PrPsc
deposition was present multifocally in placentomes
within groups of chorionic epithelial cells of the cot-
yledon but not within adjacent endometrial epithelial
cells of the interdigitating maternal caruncle (Fig. 1G).
The deposits were present within the cytoplasm of
chorionic mononuclear and multinuclear trophoblast
cells (as identified by morphology) and were appar-
ently not cell associated in the space between the fetal
cotyledon and the maternal caruncle (Fig. 1H). In the
brain, PrPsc deposits were associated with glial cells
and neurons within various nuclei of the diencephalon,
mesencephalon, metencephalon, and myelencephalon.
Detailed, scrapie strain–specific topography of central
nervous PrPsc deposits has been reported9 and was not
the subject of this study.
Effect of PrP genotype on scrapie status of the
sheep. All PrPsc-positive sheep were homozygous for
glutamine at codon 171 and homozygous for arginine
at codon 154 of the PrP gene (RR154QQ171) (Table 3).
One PrPsc-positive sheep was heterozygous for alanine
and valine at codon 136 (AV136), whereas the remain-
ing 12 PrPsc-positive sheep were homozygous for al-
anine (AA136). Thus, 12/13 PrPsc-positive sheep were
genotype AA136RR154QQ171 and 1/13 was genotype
AV136RR154QQ171. Consistent with published data on
the effect of genotype on susceptibility and incubation
period,16,28 the single PrPsc-positive AV136RR154QQ171
sheep was younger (14 mo) than the 4 youngest PrPsc-
positive AA136RR154QQ171 sheep (24 months). Tissue
distribution, cell specificity, or intensity of PrPsc de-
position did not differ between genotypes. Represen-
tation in the study was good for PrP genotypes AA136
(76/80), QQ171 (49/80), and QR171 (29/80), whereas ge-
notypes AV136 (4/80), VV136 (0/80), RH154 (1/80),
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HH154 (0/80), and RR171 (2/80) were underrepresented
(Table 3).
Potential modes of transmission. Potential modes of
scrapie transmission were investigated by analyzing
genealogy within flock A and by examining fetuses
and offspring of PrPsc-positive sheep when available.
Association of clinical scrapie with PrPsc-positive sta-
tus by genealogy was not possible in all PrPsc-positive
sheep. Not all sheep culled or removed from the flocks
because of wasting of suspect scrapie were necropsied
to definitively determine scrapie status. However, in 7/
13 PrPsc-positive sheep, in which accurate genealogy
analysis was possible, positive scrapie status followed
mother-to-daughter lineage in 57% (4/7) and was not
associated with mother-to-daughter lineage in 43% (3/
7). The single 7-year-old sheep with preclinical scrapie
was part of the latter group. Two fetuses from PrPsc-
positive ewes with clinical scrapie were available for
examination. Both ewes had PrPsc deposition in the
placenta, proving the scrapie-susceptible genotype of
the fetus,36 but neither fetus had PrPsc deposition in
fetal spleen or intestine (Table 2).
Discussion
This study demonstrates the spatial and cell-specific
preclinical accumulation pattern of PrPsc in sheep that
resemble in their PrP genotype the American Suffolk,
a breed with limited PrP gene polymorphism and pro-
longed preclinical phase. As expected from experi-
mental models,4,5,23 a buildup of PrPsc throughout the
lymphoid system can be observed during the preclin-
ical period after a lag phase during which PrPsc is not
detectable by immunohistochemistry. After the lag
phase, PrPsc accumulates rapidly in lymphoid tissues
throughout the body as well as the intestinal nervous
supply, which offers the possibility of biopsy-based
preclinical diagnosis.24,25,34,35 On the other hand, pre-
clinical dissemination of PrPsc deposits into the pla-
centa indicates a risk of horizontal and vertical trans-
mission by clinically healthy ewes. The finding that
most cases within scrapie-affected flocks are preclini-
cal underscores the significance of observing PrPsc ac-
cumulation in the placentas of a high percentage of
infected sheep.
Based on this study, the lag phase needed for PrPsc
deposits to become detectable by immunohistochem-
istry is about 12–14 months, assuming perinatal infec-
tion by oral exposure to PrPsc. This lag phase is longer
in Suffolk-type sheep with predominance of the
A136R154Q171 allele than the 2–6 months reported in
breeds with predominance of the V136R154Q171 al-
lele.1,21,35 The data thus support the notion that the pri-
mary structure of PrP determines the rate of PrPsc ac-
cumulation. From this it follows that the residues at
positions 136 and 171 determine disease susceptibility
by altering accumulation kinetics rather than accu-
mulation sites or cellular specificity. Further research
is needed to determine the nature of this kinetic barrier
and whether parameters such as time and infectious
dose modify its permissibility to accumulation and dis-
ease.
PrPsc was identified in FDCs and peripheral neurons.
PrPsc was only rarely detected in macrophages. Scant,
macrophage-associated PrPsc was occasionally detect-
ed in the medulla of lymph nodes, rather than in the
germinal centers of lymphoid follicles. This observa-
tion contrasts somewhat to a similar study that reports
early accumulation of PrPsc in tingible body macro-
phages of the germinal center.17 Failure to observe
PrPsc in tingible body macrophages may be because of
examination of tissues at a later stage of disease be-
cause PrPsc derives from scavenging exogenous PrPsc
rather than synthesis within that cell type.15
The distribution of PrPsc observed in this study un-
derscores the importance of the germinal center and
FDC for the peripheral amplification of PrPsc and is
consistent with neurogenic spread from sites of pri-
mary amplification to the CNS. Our observations sup-
port the role of FDC for scrapie pathogenesis6 and are
in line with experiments that report drastically reduced
susceptibility of mice to scrapie on dedifferentiation of
FDC.20 Furthermore, the proximity of nerve endings
and PrPsc in lymphoid follicles has been demonstrat-
ed.14,31 Conversely, in this study the authors failed to
observe a pattern of PrPsc accumulation in lymphoid
tissues that would suggest travel of PrPsc through the
lymphatic vessels or blood stream. For instance, PrPsc
was not detected in the glandular tissue of the mam-
mary gland, the tributary region of the mammary
lymph nodes; yet, the mammary lymph node regularly
accumulated PrPsc. Likewise, PrPsc was not detected in
the bone marrow or splenic red pulp and was only
rarely detected in macrophages within lymph nodes.
The mode by which generalized depositional disease
throughout the lymphoid tissue is initiated and syn-
chronized has been elusive; however, episodic hema-
togenous dispersion of cells carrying PrPsc below the
detection level of immunologic assays is a possibility.
Large, intrauterine PrPsc deposits occurred during
preclinical and clinical disease and were restricted to
the (fetal) chorionic epithelium of the placentome,
whereas no PrPsc was detected in adjacent maternal
tissues or tissues of the fetus proper. This observation
is consistent with the well-recognized infectivity of fe-
tal membranes.32 Similar to Andreoletti et al.,2 PrPsc
was found to be restricted to fetal tissues. Because
placentomes were not analyzed specifically for mac-
rophages, the possibility of PrPsc deposits occurring in
macrophages of the (maternal) caruncle or at the in-
terface between fetal and maternal tissues remains.
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The finding of Andreoletti et al.2 is in contrast to those
of Tuo et al.,37 who observed PrPsc deposits also in the
caruncular epithelium, albeit the latter study did not
use double immunohistochemistry to ascertain cellular
specificity
Natural transmission of sheep scrapie is thought to
occur most commonly by perinatal maternal transmis-
sion through oral exposure of neonates to prions within
the secundines and placental fluids,7,32 a mechanism
supported by the findings of this study. Infection of
placental membranes is reportedly restricted to suscep-
tible fetal genotypes.36 In this study, transmission fol-
lowed ewe-to-lamb lines in most scrapie-affected
sheep, and there was abundant PrPsc deposition within
and around placental trophoblast cells. PrPsc was not
evident in 2 genetically susceptible fetuses, supporting
other studies arguing against direct intrauterine trans-
mission of scrapie or infectivity of the fetus proper.2,12
However, horizontal transmission is reported to occur
in heavily infected flocks.39 Similarly, this study
showed transmission outside the ewe-to-lamb lines in
43% of cases; for example, preclinical scrapie was di-
agnosed in a 7-year-old ewe. Understanding how PrP
polymorphism affects PrP conversion and PrPsc depo-
sition in specific tissues and cell types, especially those
at potential sites of preclinical accumulation, is critical
to the development of treatment or control measures
for the scrapie-type TSE.
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